Blocking Timp1 expression with siRNA increased the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine and reversed their resistance to chemotherapy; the combined action of shTIMP1 therapy and gemcitabine induced apoptosis of tumor cells [101]. This evidence concerns the gene TIMP1 and pancreatic ductal adenocarcinoma.